Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;119(1):99-106.
doi: 10.1016/j.fertnstert.2022.10.014. Epub 2022 Nov 29.

Markers of ovarian reserve as predictors of future fertility

Benjamin S Harris  1 , Anne Marie Jukic  2 , Tracy Truong  3 , Caroline T Nagle  4 , Alaattin Erkanli  3 , Anne Z Steiner  5
Affiliations

Markers of ovarian reserve as predictors of future fertility

Benjamin S Harris et al. Fertil Steril. 2023 Jan.

Abstract

Objective: To determine the association between ovarian reserve biomarkers and future fertility among late reproductive-age women.

Design: Cohort study of participants enrolled in Time to Conceive (TTC), a time-to-pregnancy cohort study of the ovarian reserve biomarkers.

Setting: Community.

Patient(s): Women aged 30-44 years without a history of infertility who provided a blood sample at enrollment in TTC and who agreed to future follow-up.

Intervention(s): Not applicable.

Main outcome measure(s): The primary outcomes were probability of achieving a live birth >3 years after enrollment in TTC, diagnosis of infertility at any time, and time-to-pregnancy in future pregnancy attempts.

Result(s): Women with diminished ovarian reserve, defined as those with an antimüllerian hormone (AMH) level <0.7 ng/mL or follicle-stimulating hormone (FSH) level ≥10 mIU/mL, did not have low risk of future live birth (relative risk [RR], 1.32; 95% confidence interval [CI], 0.95-1.83 and RR, 1.28; 95% CI, 0.97-1.70, respectively) compared with women with normal ovarian reserve after adjusting for age at blood draw, race, obesity, use of hormonal contraception, and year of enrollment in original study. Among women in the cohort that attempted to conceive, there was not a significant association between diminished ovarian reserve, as measured by AMH or FSH, and risk of future infertility (RR, 0.65; 95% CI, 0.21-2.07 and RR,1.69; 95% CI, 0.86-3.31, respectively). Similarly, there was no association between AMH and FSH levels and future fecundability (fecundability ratio, 0.97; 95% CI, 0.59, 1.60; and fecundability ration, 0.86; 95% CI, 0.55-1.36, respectively).

Conclusion: Diminished ovarian reserve is not associated with reduced future reproductive capacity. Given the lack of association, women should be cautioned regarding use biomarkers of ovarian reserve as predictors of their future reproductive capacity.

Keywords: Ovarian reserve; antimüllerian hormone; biomarkers; fertility potential.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest. No other disclosures were reported.

References

    1. Matthews TJ and Hamilton BE, Mean Age of Mothers is on the Rise: United States, 2000–2014. NCHS Data Brief 2016; 232:1–8. - PubMed
    1. Steiner AZ and Jukic AM, Impact of female age and nulligravidity on fecundity in an older reproductive age cohort. Fertil Steril 2016; 105:1584–1588 e1. - PMC - PubMed
    1. Practice Committee of the American Society for Reproductive, M., Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2015; 103:e9–e17. - PubMed
    1. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, and Klein NA, A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 2008; 23:699–708. - PubMed
    1. Meczekalski B, Czyzyk A, Kunicki M, Podfigurna-Stopa A, Plociennik L, Jakiel G, et al., Fertility in women of late reproductive age: the role of serum anti-Mullerian hormone (AMH) levels in its assessment. J Endocrinol Invest 2016; 39:1259–1265. - PMC - PubMed

Publication types